HARVARD BIOSCIENCE INC (HBIO) Stock Analyst Ratings
NASDAQ:HBIO - Nasdaq - US4169061052 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to HBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.59. This target is 882.87% above the current price.
HBIO was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about HBIO.
In the previous month the buy percentage consensus was at a similar level.
HBIO was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-13 | Benchmark | Maintains | Speculative Buy -> Speculative Buy |
| 2025-04-09 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2025-04-08 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2025-03-24 | Benchmark | Maintains | Speculative Buy -> Speculative Buy |
| 2023-06-22 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-04-26 | Keybanc | Maintains | Overweight |
| 2023-04-26 | Benchmark | Maintains | Buy |
| 2023-03-10 | Benchmark | Reiterate | Buy |
| 2022-11-09 | Keybanc | Maintains | Overweight |
| 2022-08-05 | Keybanc | Maintains | Overweight |